Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate Cancer. - Xu, Pengfei; Qu, Huan; Yang, Joy C.; Wei, Fan; Zhao, Junwei; Tang, Menghuan; Wang, Leyi; Nip, Christopher; Li, Henson; Gao, Allen C.; Lam, Kit; Dall'Era, Marc; et al. (Cancers, 2025)